The "Smart Syringes Market Forecast to 2033" has been added to ResearchAndMarkets.com's offering.
The global smart syringes market is set for robust growth, with an estimated size of USD 1.05 billion in 2024 and a projection to reach USD 2.22 billion by 2033. This represents a CAGR of 8.7% from 2025 to 2033, driven by a heightened focus on safety for both patients and healthcare workers. Rising cases of Needle Stick Injuries (NSIs) and transmission of blood-borne infections like HIV and hepatitis underscore the urgency for smart syringes. Governments, particularly in countries such as India, are amplifying vaccine initiatives, fueling the demand for auto-disable smart syringes.
The healthcare landscape is witnessing regulatory bodies in the U.S. and Europe mandating safety-engineered injection devices, further propelling smart syringe adoption. These syringes, featuring retractable needles or auto-disable mechanisms, play a crucial role in minimizing accidental needle-stick injuries, a significant public health concern, especially in medical and surgical departments where over 50% of incidents occur. High-risk environments include trauma (38%) and operating rooms (3%), with insulin administration in diabetic patients marking a notable source of NSIs.
Globally, NSI prevalence is significant among nurses (42.8%), doctors (46.4%), and nursing students (45.3%). Moreover, initiatives aimed at greater immunization, especially in developing nations, enhance the demand for auto-disable syringes designed for single use, effectively preventing reuse and boosting vaccine safety. India's Universal Immunization Programme (UIP) serves as a prime example, annually reaching 26.7 million newborns and 29 million pregnant women, striving to lower under-five mortality rates.
The rising incidence of blood-borne diseases such as HIV and hepatitis B and C further drives the smart syringe market. Unsafe injection practices, particularly in developing regions, are substantial contributors to these diseases' spread. Smart syringes are key to reducing these risks by preventing reuse and accidental injuries.
The companies profiled in this Smart Syringes market report include:
- Becton, Dickinson and Company (BD)
- Hindustan Syringes & Medical Devices (HMD)
- Terumo Corporation
- Nipro Corporation
- Retractable Technologies, Inc.
- SCHOTT Pharma
- Schreiner MediPharm
- Gerresheimer AG
- SPM Medicare
- Restek Corporation
- Shimadzu
- Trajan LPP
- Liaoning Kangyi Medical Equipment Co., Ltd.
- AccuPoint (AdvaCare Pharma)
- Agilent
Global Smart Syringes Market Report Segmentation
This comprehensive report offers revenue forecasts at global, regional, and country levels, detailing the latest industry trends across various sub-segments from 2021 to 2033. The market is segmented based on product, application, distribution channel, technology, and region.
Product Outlook (Revenue, USD Million, 2021-2033)
- Auto-Disable Syringes
- Active Safety Syringes
- Passive Safety Syringes
Application Outlook (Revenue, USD Million, 2021-2033)
- Drug Delivery
- Blood Specimen Collection
- Catheter Syringe Flushing
- Other Specialized Injection
Distribution Channel Outlook (Revenue, USD Million, 2021-2033)
- Direct Tenders (Government & NGOs)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Technology Outlook (Revenue, USD Million, 2021-2033)
- Needle Retractable Technology
- Needle Shielding Technology
Regional Outlook (Revenue, USD Million, 2021-2033)
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Why You Should Buy This Report
- Comprehensive Market Analysis: Detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the presence of key players.
- Future Trends: Discover trends and drivers shaping the market's future.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic decisions.
Report Deliverables
- Market intelligence for effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings to stay ahead of the curve
Key Attributes
| Report Attribute | Details |
| No. of Pages | 120 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value (USD) in 2024 | $1.05 Billion |
| Forecasted Market Value (USD) by 2033 | $2.22 Billion |
| Compound Annual Growth Rate | 8.7% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/sp7fnm
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251202823534/en/
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900